CAS: 65652-44-0; Pirbuterol Acetate

该化合物是一种选择性的β-2-肾上腺素受体激动剂,主要用作治疗哮喘和慢性阻塞性肺病(COPD)等呼吸状况的支气管止动器.其乙酸盐形式增强了稳定性和生物利用率,确保了持续的治疗效果.该化合物显示出行动迅速的开端,有效地放松支气管滑动肌肉以缓解气道阻塞.皮质丁醇乙酸酯的区别在于它偏好针对肺部受体,最大限度地减少系统副作用,如心血管刺激.其药源动力学特征支持方便的剂量,使其适合急性症状缓解和维持治疗.该化合物通常通过吸入来进行调节,以最大限度地发挥局部效应,同时减少系统性接触.

结构式图片

欧盟法规

C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2025206743-A1
    优先权日:2022-03-25
    标 题:Tyk2 inhibitor synthesis and intermediates thereof
    发明人:MASSE CRAIG E; PHADKE AVINASH S; LAWSON JON P; LEVY STUART; YANG XIAOWEI; WU GUISHENG; FAN SHUFENG
    权利人:TAKEDA PHARMACEUTICALS CO
    摘要:Described herein are methods of synthesis of a tyrosine-protein kinase 2 (TYK2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. Also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.

    专利号:US-8697730-B2
    优先权日:2007-10-26
    标题 :5-lipoxygenase activating protein (FLAP) inhibitor
    发明人:REWOLINSKI MELISSA VIRGINIA; SCHAAB KEVIN MURRAY; KING CHRISTOPHER DAVID; STOCK NICHOLAS SIMON
    权利人:REWOLINSKI MELISSA VIRGINIA; SCHAAB KEVIN MURRAY; KING CHRISTOPHER DAVID; STOCK NICHOLAS SIMON; PANMIRA PHARMACEUTICALS LLC
    摘要:Described herein are methods for the synthesis of 3-[5-(pyridin-2-ylmethoxy)-3-(2-methyl-2-propylthio)-1-[4-(2-methoxypyridin-5-yl)benzyl]-indol-2-yl]-2,2-dimethyl-propionic acid, pharmaceutically acceptable salts, pharmaceutically acceptable solvates thereof. Also described are pharmaceutical compositions suitable for oral administration to a mammal that include, as well as methods of using such oral pharmaceutical compositions for treating respiratory conditions or diseases, as well as other leukotriene-dependent or leukotriene mediated conditions or diseases.

    专利号:CN-118922420-A
    优先权日:2022-03-25
    标题 :Synthesis of TYK2 inhibitors and their intermediates

    专利号:EP-3835297-B1
    优先权日:2010-03-25
    标题:Synthesis and intermediates of (r)-1(2,2 -difluorobenzo[d][1,3]dioxol-5yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2yl)-1h-indol-5yl)cyclopropanecarboxamide
    发明人:KESHAVARZ-SHOKRI ALI; ZHANG BEILI; ALCACIO TIM EDWARD; LEE ELAINE CHUNGMIN; ZHANG YUEGANG; KRAWIEC MARIUSZ
    权利人:VERTEX PHARMA

    专利号:US-2014315720-A1
    优先权日:2012-10-24
    标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
    发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
    权利人:CELANESE ACETATE LLC
    摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

    专利号:EP-3835297-A1
    优先权日:2010-03-25
    标题 :Synthesis and intermediates of (r)-1(2,2 -difluorobenzo[d][1,3]dioxol-5yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2yl)-1h-indol-5yl)cyclopropanecarboxamide

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Langley PC. The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and- breathe inhalers. Clin Ther. 1999 Jan;21(1):236-53. doi: 10.1016/S0149-2918(00)88281-8. 79(4):333-8. doi: 10.1016/S1081-1206(10)63024-4. 28(4):306-10. doi: 10.1111/j.2042-3306.1996.tb03094.x. 92(6):783-9. doi: 10.1016/0091-6749(93)90054-j. 30(6):439-43. doi: 10.3109/02770909309056752. 26(5):309-15. doi: 10.3109/02770908909073268. 48(1):14-20. 1(6):426-31. doi: 10.1016/s0272-0590(81)80022-x.

    合成参考文献


    参考文献:10.2165/00003495-198530010-00002
    摘要:Richards DM, Brogden RN. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease. Drugs. 1985 Jul;30(1):6–21. doi: 10.2165/00003495-198530010-00002.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知